BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BSB-2002 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of BSB-2002\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07583303-3074@assetmemo.bio
DTSTAMP:20261121T005318Z
DTSTART;VALUE=DATE:20270416
DTEND;VALUE=DATE:20270417
SUMMARY:BSB-2002: Phase 1 readout est. (NCT07583303)
DESCRIPTION:BSB-2002\, phase 1\, Acute Myeloid Leukemia.\nStudy: BSB-2002 A
 fter Cyclophosphamide and Fludarabine for the Treatment of Relapsed or Ref
 ractory Acute Myeloid Leukemia Patients With NPM1 Mutation\nEstimated prim
 ary completion: 16 April 2027. This is a ClinicalTrials.gov estimate\, not
  a confirmed readout date\, and it can move.\nDrug page: https://assetmemo
 .bio/drug/bsb-2002#upcoming-events\nRegistry record: https://clinicaltrial
 s.gov/study/NCT07583303
URL:https://assetmemo.bio/drug/bsb-2002#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
